drugset / Trial / NCT00630825
A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus
RandomizedParallel-groupTriple-blindTreatment
Summary
To study once weekly injections of LY2189265 compared to placebo on blood glucose by measuring glycosylated hemoglobin (HbA1c) change from baseline after 16 weeks in overweight Type 2 Diabetes Mellitus participants.
Timeline
- Start
- 2008-04
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dulaglutide | Peptide | 1 mg | Subcutaneous |
| Subject | Dulaglutide | Peptide | 2 mg | Subcutaneous |